Erlich is credited with the first liver aspiration in 1883 and subsequently the first percutaneous liver biopsy for diagnostic purposes was reported in 1923. The technique has been modified since then, and over the past 50 years it has become a central investigation of hepatic disease. The low mortality (0.01–0.17%) and the relatively low morbidity of this procedure have meant that liver biopsy has become widely used. Advances in medical technology and especially in imaging, together with advances in drug therapy have greatly influenced the diagnosis and management of hepatic disease and as a consequence the indications for liver biopsy are changing. In 1991 the British Society of Gastroenterology (BSG), together with the Royal College of Physicians of London, undertook a nationwide audit of percutaneous liver biopsy in 189 health districts. It is clear from this audit and from reviewing the literature that there continue to be significant differences in clinical practice with respect to liver biopsy across the United Kingdom, and a lack of standardised protocols between institutions. These guidelines examine the evidence for methods of liver biopsy in adults.
肝脏活组织检查临床实践指南
发布日期:1999-01-01
英文标题:Guidelines on the use of liver biopsy in clinical practice
来源:Gut, 1999, 45(Suppl IV): IV1–IV11
阅读次数:945
- 1 病毒性肝炎431
- 1.1 乙型肝炎225
- 1.2 丙型肝炎162
- 1.3 甲型肝炎5
- 1.4 戊型肝炎10
- 1.5 其他肝炎29
- 2 肝硬化及并发症148
- 3 酒精性肝病39
- 4 代谢相关脂肪性肝病85
- 5 肝衰竭/肝性脑病/人工肝89
- 6 肝肿瘤278
- 7 自身免疫性肝病51
- 8 药物性肝病46
- 9 肝移植95
- 10 其他肝病92
- 10.1 遗传及代谢性肝病45
- 10.2 胆汁淤积性肝病28
- 10.3 肝脏血管病19
- 11 一般肝病/肝脏检查141
- 12 胆道疾病191
- 13 胰腺疾病353
- 14 全身疾病与肝病/内镜101
- 15 肝胆胰疾病相关评分系统汇总18